Hypertension trials recruiting in District of Columbia

All Hypertension trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
  NCT05321368 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
  NCT07218029 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
  NCT07175038 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
  NCT06059638 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Natural History of Sickle Cell Disease
  NCT00081523 · Phase: Not specified · Ages: 2 Years to 90 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Non-invasive Central Venous Pressure Estimation in Pediatric Patients
  NCT06885073 · Phase: Not applicable (e.g. observational or device study) · Ages: Up to 21 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
  NCT04669548 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
  NCT05587712 · Phase: Phase 2 · Ages: 1 Year to 17 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.